Apart from the previously mentioned genes, amplifications were also found in BCL2L2 (1.8%; STS NOS and bone OS), C17orf39 (1.8%; STS NOS and LMS), CKS1B (1.8%; two LMS), FRS2 (1.9%; LPS), ERBB2 (0.9%; MPNST), MYC (1.8%; angiosarcoma and ARMS), CSF3R (0.9%; ARMS), ESR1 (0.9%; LPS), HGF (0,9%; STS NOS), JUN (0.9%; STS NOS), KDM5A (0.9%; bone OS), MCL1 (0.9%, ARMS), MYC (1.9%; angiosarcoma and ARMS), NTRK (0.9%; ARMS), RAD21 (0.9%; ARMS), and RICTOR (0.9%; STS NOS) genes. This evidence concerns the gene ERBB2 and angiosarcoma.